1. Han, Jing, Zhang, Xue, Liu, Yan, Liu, Yi-Bing, Feng, Li. . CLCA4 and MS4A12 as the significant gene biomarkers of primary colorectal cancer. In Bioscience reports, 40, . doi:10.1042/BSR20200963. https://pubmed.ncbi.nlm.nih.gov/32797167/
2. Suenaga, Mitsukuni, Schirripa, Marta, Cao, Shu, Falcone, Alfredo, Lenz, Heinz-Josef. 2021. Clinical significance of enterocyte-specific gene polymorphisms as candidate markers of oxaliplatin-based treatment for metastatic colorectal cancer. In The pharmacogenomics journal, 21, 285-295. doi:10.1038/s41397-021-00207-x. https://pubmed.ncbi.nlm.nih.gov/33542444/
3. He, L, Deng, H Y, C Wang, X. . Decreased expression of MS4A12 inhibits differentiation and predicts early stage survival in colon cancer. In Neoplasma, 64, 65-73. doi:10.4149/neo_2017_108. https://pubmed.ncbi.nlm.nih.gov/27881006/
4. Koslowski, Michael, Türeci, Ozlem, Huber, Christoph, Sahin, Ugur. 2009. Selective activation of tumor growth-promoting Ca2+ channel MS4A12 in colon cancer by caudal type homeobox transcription factor CDX2. In Molecular cancer, 8, 77. doi:10.1186/1476-4598-8-77. https://pubmed.ncbi.nlm.nih.gov/19781065/
智鼠故事 
